These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1107 related articles for article (PubMed ID: 1995878)
1. 31P NMR and chloride ion kinetics of alkylating monoester phosphoramidates. Fries KM; Borch RF J Med Chem; 1991 Feb; 34(2):565-9. PubMed ID: 1995878 [TBL] [Abstract][Full Text] [Related]
2. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard. Boal JH; Williamson M; Boyd VL; Ludeman SM; Egan W J Med Chem; 1989 Aug; 32(8):1768-73. PubMed ID: 2754703 [TBL] [Abstract][Full Text] [Related]
3. 31P NMR investigations of phosphoramide mustard: evaluation of pH control over the rate of intramolecular cyclization to an aziridinium ion and the hydrolysis of this reactive alkylator. Engle TW; Zon G; Egan W J Med Chem; 1979 Aug; 22(8):897-9. PubMed ID: 40026 [No Abstract] [Full Text] [Related]
4. Kinetics of phosphoramide mustard hydrolysis in aqueous solution. Watson E; Dea P; Chan KK J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195 [TBL] [Abstract][Full Text] [Related]
5. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions. Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475 [TBL] [Abstract][Full Text] [Related]
6. 31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine. Engle TW; Zon G; Egan W J Med Chem; 1982 Nov; 25(11):1347-57. PubMed ID: 7143373 [No Abstract] [Full Text] [Related]
7. Synthesis and antitumor properties of activated cyclophosphamide analogues. Borch RF; Canute GW J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355 [TBL] [Abstract][Full Text] [Related]
9. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents. Steinberg G; Borch RF J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089 [TBL] [Abstract][Full Text] [Related]
11. The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions. Shulman-Roskes EM; Noe DA; Gamcsik MP; Marlow AL; Hilton J; Hausheer FH; Colvin OM; Ludeman SM J Med Chem; 1998 Feb; 41(4):515-29. PubMed ID: 9484502 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide. Struck RF; Schmid SM; Waud WR Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, activation, and cytotoxicity of aldophosphamide analogues. Borch RF; Valente RR J Med Chem; 1991 Oct; 34(10):3052-8. PubMed ID: 1920356 [TBL] [Abstract][Full Text] [Related]
15. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues. Jouin P; Poncet J; Dufour MN; Aumelas A; Pantaloni A; Cros S; François G J Med Chem; 1991 Feb; 34(2):486-91. PubMed ID: 1995869 [TBL] [Abstract][Full Text] [Related]
16. Protonation of phosphoramide mustard and other phosphoramides. Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides. Lin TS; Fischer PH; Prusoff WH J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673 [TBL] [Abstract][Full Text] [Related]
18. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways. Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049 [TBL] [Abstract][Full Text] [Related]
19. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia. Zaharko DS; Covey JM; Hörpel G Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508 [TBL] [Abstract][Full Text] [Related]